Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101759602B details non-phosgene route enhancing purity and supply chain stability for global carbamate intermediate procurement strategies.
Patent CN107417573A reveals metal amide catalysis for carbamate. Offers high purity, atmospheric pressure, and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1761642A details an efficient asymmetric hydrogenation process for chiral beta-amino acids, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN111217841B introduces a stable nitrogen-phosphine silver reagent for stereospecific trifluoromethoxylation, enabling reliable pharmaceutical intermediate supplier capabilities.
Novel organometallic palladium method for Elagolix intermediate. Reduces steps, avoids mesyl chloride, ensures high purity for pharmaceutical supply chains.
Patent CN102285934B details a novel transition metal-catalyzed synthesis of spirocyclic dienones with significant anti-tumor activity, offering cost-effective API manufacturing solutions.
Patent CN109305983B reveals a novel ethylene-based route for cyclopropylboronic acid, eliminating hazardous cyclopropyl bromide and offering significant supply chain stability.
Novel rhodium-catalyzed method reduces noble metal usage and simplifies purification for high-yield carbapenem antibiotic intermediates.
Patent CN115703809A details a copper-catalyzed route to benzo-phosphole compounds, offering a cost-effective and scalable solution for organic electronic chemical manufacturing.
Patent CN106146543A details efficient Rh-catalyzed synthesis of chiral alpha-amino tertiary borates, offering cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN1314880A details a novel enantioselective hydrocyanation method for producing high-purity optically active alpha-aminonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110885341B reveals a transition-metal-free borylation method using alkyl bromides. This breakthrough offers cost reduction in fine chemical manufacturing and high-purity alkyl boronic esters.
Patent CN114213383B reveals a room-temperature Ru-catalyzed route for isocoumarins. Discover cost reduction in fine chemical manufacturing and high-purity scalability.
Patent CN102076634A details enantioselective hydrogenation of N-H imines. Discover cost-effective routes for high-purity pharmaceutical intermediates without protection steps.
Discover the advanced CN102417486B synthesis method for Valsartan. Achieve higher yields and cost reduction in API manufacturing with our optimized zinc-mediated route.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Patent CN114874134A details a protection-free asymmetric synthesis of nicotine using Ir-catalysis, offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Novel Zn-N complex enables 99% transformation efficiency in Henry reactions. Reduces heavy metal waste significantly. Reliable supplier for high-purity pharma intermediates.
Patent CN105189524A enables high-yield chiral amino acid production with recoverable auxiliaries for scalable pharmaceutical manufacturing supply chains and cost-effective commercialization strategies.
Patent CN111606962A details a safe levonorgestrel synthesis avoiding lithium ammonia, offering high purity and yield for reliable API intermediate supply chains.